1994
DOI: 10.1016/0968-0896(94)85014-3
|View full text |Cite
|
Sign up to set email alerts
|

Polyclonal antibodies and catalysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

1996
1996
2001
2001

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…These values are termed ' apparent ' to emphasize that they characterize the polyclonal samples as a whole. Use of the fractions determined in the inhibition studies to estimate the catalyst concentration permits the calculation of the apparent k cat values also listed in Table 2 [11,[13][14][15][16][17]. In addition, the values of apparent k cat \k uncat can be calculated ; these are also listed in Table 2.…”
Section: Figure 1 Representative Inhibition and Lineweaver-burk Plotsmentioning
confidence: 99%
See 1 more Smart Citation
“…These values are termed ' apparent ' to emphasize that they characterize the polyclonal samples as a whole. Use of the fractions determined in the inhibition studies to estimate the catalyst concentration permits the calculation of the apparent k cat values also listed in Table 2 [11,[13][14][15][16][17]. In addition, the values of apparent k cat \k uncat can be calculated ; these are also listed in Table 2.…”
Section: Figure 1 Representative Inhibition and Lineweaver-burk Plotsmentioning
confidence: 99%
“…The great majority of previous catalytic antibody studies have utilized monoclonal antibodies. In contrast, antibody catalysis has been reported in polyclonal antibody preparations isolated from the sera of immunized animals [8][9][10][11][12][13][14][15][16][17][18][19]. Compared with monoclonal antibody studies, the investigation of antibody catalysis with polyclonal antibodies is substantially faster and far less expensive.…”
Section: Introductionmentioning
confidence: 99%
“…The finding (reviewed in [12]) that, despite early discouraging results [13,14], substantial catalytic activities can be generated reproducibly in polyclonal preparations [15][16][17][18][19][20] suggests valuable opportunities for studies and applications complementary to those involving monoclonal catalytic antibodies. The particular value of the former, pointed out in [16] and emphasized by others [12,20,21], includes : (i) the relative simplicity of producing polyclonal as against monoclonal antibodies, (ii) their potential value as catalysts for technological applications, (iii) the rapid and cost-effective application in evaluating a range of haptens for production of catalytic activity, and (iv) their potential value in the development of novel therapies when produced by active immunization [18,19]. Because polyclonal IgG necessarily represents the entirety of the immune response, the relative immunogenic capabilities of a series of haptens may be assessed more effectively than by studies on a small selection of isolated monoclonal antibodies [20].…”
Section: Introductionmentioning
confidence: 99%
“…Reasons for the growing interest in polyclonal catalytic antibody (PCA) preparations (e.g. Gallacher et al, 1991Gallacher et al, , 1992Gallacher et al, , 1993Green & Glikson, 1991;Stephens et al, 1994;Suzuki, 1994;Resmini et al, 1997) include: the relative simplicity of producing PCAs, their potential value in technological applications, the rapid and cost-e!ective application in evaluating a range of haptens for catalyst production and their potential value in the development of novel therapies when produced by active immunization. Because polyclonal IgG necessarily represents the entirety of the immune response, the relative immunogenic capabilities of a series of haptens may be assessed more e!ectively by using PCAs than by studies on a small selection of isolated monoclonal catalytic antibodies.…”
Section: Introductionmentioning
confidence: 99%